Cancer stem cells are remarkably similar to normal stem cells: both self-renew, are multipotent and express common surface markers, for example, prominin 1 (PROM1, also called CD133) 1 . What remains unclear is whether cancer stem cells are the direct progeny of mutated stem cells or more mature cells that reacquire stem cell properties during tumour formation. Answering this question will require knowledge of whether normal stem cells are susceptible to cancer-causing mutations; however, this has proved difficult to test because the identity of most adult tissue stem cells is not known. Here, using an inducible Cre, nuclear LacZ reporter allele knocked into the Prom1 locus (Prom1 C-L ), we show that Prom1 is expressed in a variety of developing and adult tissues. Lineage-tracing studies of adult Prom1 1/C-L mice containing the Rosa26-YFP reporter allele showed that Prom1 1 cells are located at the base of crypts in the small intestine, co-express Lgr5 (ref. 2) , generate the entire intestinal epithelium, and are therefore the small intestinal stem cell. Prom1 was reported recently to mark cancer stem cells of human intestinal tumours that arise frequently as a consequence of aberrant wingless (Wnt) signalling [3] [4] [5] . Activation of endogenous Wnt signalling in Prom1 1/C-L mice containing a Cre-dependent mutant allele of b-catenin (Ctnnb1 lox(ex3) ) resulted in a gross disruption of crypt architecture and a disproportionate expansion of Prom1 1 cells at the crypt base. Lineage tracing demonstrated that the progeny of these cells replaced the mucosa of the entire small intestine with neoplastic tissue that was characterized by focal high-grade intraepithelial neoplasia and crypt adenoma formation. Although all neoplastic cells arose from Prom1 1 cells in these mice, only 7% of tumour cells retained Prom1 expression. Our data indicate that Prom1 marks stem cells in the adult small intestine that are susceptible to transformation into tumours retaining a fraction of mutant Prom1 1 tumour cells.
The hypothesis that cancers are generated by rare populations of cancer stem cells that are more tumorigenic than other cancer cells has gained increasing credence 1 . This has followed consistent observations that some solid tumours and leukaemias contain small numbers of self-renewing cells that propagate the disease when transplanted in mice 3, 4, [6] [7] [8] . Cancer stem cells also express markers of normal stem cells, and in the brain, exist in microenvironments that mimic normal stem cell niches 9, 10 .
Although there is an expanding literature to support the existence of cancer stem cells, important caveats of these studies continue to provoke debate. The current definitive test of a cancer stem cell is the capacity to propagate tumours as xenografts in immunocompromized mice 11 ; however, it has been argued that species differences alone might account for the selective growth of subpopulations of cells in these assays. Indeed, most cells in a mouse lymphoma were shown recently to possess tumour-initiating capacity when allografted into syngenic mice 12 . Further controversy has surrounded the use of stem cell surface markers to isolate cancer stem cells. Notable among these is PROM1, a five-transmembrane-domain-containing glycoprotein that is expressed on the surface of a variety of normal stem cells [13] [14] [15] . Cancer stem cells of brain 7, 16 , gut 3, 4 and pancreatic 17 tumours have been isolated using PROM1 antibodies; however, most PROM1 antibodies recognize glycosylation-dependent epitopes that vary with the differentiation and transformation status of the cell 18 , complicating the use of these reagents to fractionate stem cells. Without better understanding of normal tissue stem cells and their susceptibility to neoplastic transformation, it will be difficult to conduct definitive studies of the existence and origins of cancer stem cells.
To understand better the identity of normal tissue stem cells and their role in the cancer process, we generated a knockin allele in which we integrated a creER T2 -IRES-nlacZ cassette (where nlacZ indicates nuclear lacZ) at the first ATG codon of Prom1 (Prom1 C-L ), thereby creating a null allele ( Fig. 1a and Supplementary Fig. 1 ). Prom1 C-L/C-L mice were born and aged normally, indicating that Prom1 is dispensable for gross embryonic and postnatal development. nLacZ expression in Prom1 1/C-L embryos that retained one copy of the wild-type allele was restricted to the central nervous system, kidney, intestine and developing skeletal system (Fig. 1b ). The tissue distribution of Prom1 expression increased with subsequent development and was detected ultimately in several organs of adult Prom1 1/C-L mice ( Fig. 1c , Supplementary Fig. 2 and Supplementary Table 1 ). Analysis of nLacZ and Prom1 protein expression from the modified and wild-type alleles, respectively, as well as tissue-specific markers, detected Prom1 in Nestin 1 cells of the ependymal layer and subventricular zone of the adult brain; Clara cell specific protein (CCSP) 1 cells at the bronchoalveolar junction in the lung; and cells lining the pancreatic ducts (Fig. 1c ). Each of these cell populations has been reported to include adult stem cells [19] [20] [21] [22] . nLacZ and Prom1 expression was also observed in numerous differentiated cells in Prom1 1/C-L mice, including proximal renal tubule cells, photoreceptors in the retina (both Fig. 1c ), neurons in the adult brain, acinar and islet cells in the pancreas, and goblet and columnar epithelial cells lining the colon ( Supplementary Fig. 2 ). This pattern of Prom1 expression is in agreement with recent studies of the Prom1 locus in mouse tissues 23 , and indicates that Prom1 expression is not confined to stem cells, but is expressed also in multiple types of differentiated cells.
In contrast to most tissues, Prom1 expression was relatively restricted in the small intestine of Prom1 1/C-L adult mice. Less than 3% of cells covering the villi expressed nLacZ (n 5 82 out of 3,305), versus 26% (n 5 106 out of 402) of cells at the crypt base (b-galactosidase staining, P , 0.0001, chi-squared test, Fig. 2a and Supplementary  Fig. 3 ). Prom1 messenger RNA expression was similarly distributed in the small intestine and overlapped closely with that of Lgr5, which was reported recently to mark intestinal stem cells 2 (Fig. 2b, c and Supplementary Fig. 3 ). Therefore, as a first step to test if Prom1 might be expressed by Lgr5 1 crypt stem cells, we performed concurrent Lgr5 in situ hybridization and nLacZ immunofluorescence analyses of adult Prom1 1/C-L mouse small intestine. Over 75% of Lgr5 1 crypt cells contained nLacZ 1 nuclei (n 5 390 out of 500 cells counted), suggesting that Prom1 1 crypt cells are predominantly stem cells (Fig. 2d ). Furthermore, out of the 4.1 LacZ-positive nuclei (average, range 0-8 cells in 210 crypts counted) observed in each Prom1 1/C-L crypt, 23%, 30% and 17% were located at the 0, 19 and 29 cell positions, respectively, that are the sites most frequently occupied by Lgr5 1 cells 2 (Fig. 2e ). Together, these data indicate that Lgr5 1 small intestinal stem cells express Prom1.
To test more directly whether Prom1 marks stem cells in the small intestine, we used the Cre-dependent Rosa26-yellow fluorescence protein (Rosa26-YFP) reporter allele to trace the lineage of Prom1 1 crypt cells. Two-month-old Prom1 1/C-L ; Rosa26-YFP mice were treated with tamoxifen to activate CreER T2 expressed from the Prom1 C-L locus; thereby irreversibly activating YFP expression in Prom1 1 cells and their progeny. Mice were killed 2, 10 and 60 days after induction. Two days after induction, an average of 2.5 YFPlabelled cells was seen in 25% of small intestinal crypts (.50 labelled crypts counted; Fig. 2f , inset). By 10 days, trains of contiguous YFP 1 cells were observed emanating in single file from the base of crypts in a manner identical to that reported for the progeny of Lgr5 1 stem cells 2 (Fig. 2g ). YFP cells remained present at 60 days, extended to the tip of the villi, and included the four differentiated cell types of the intestinal lining: enterocytes, Paneth cells, goblet cells and enteroendocrine cells ( Fig. 2f and Supplementary Fig. 4 ). Thus, we conclude that the stem cells of the mouse small intestine are Prom1 1 . In contrast, immediately after induction, YFP labelling in the colon of these mice displayed the same broad distribution as Prom1 expression, and gradually disappeared within 60 days. Therefore, Lgr5 1 / Prom1 1 stem cells of the small intestine are distinct from Lgr5 1 / Prom1 2 stem cells of the large intestine 2, 23 . YFP labelling of the brain, kidney, lung and pancreas remained relatively static between 2 and 60 days after tamoxifen induction ( Supplementary Fig. 5 and data not shown). Because these organs have low rates of cell turnover, it remains possible that some Prom1 1 cells in these tissues are quiescent adult stem cells.
Mutations that activate aberrant Wnt signalling, including mutations in b-catenin (CTNNB1), have been identified in over 80% of human colonic cancers 5, 24 and this tumour type was reported recently to contain Prom1 1 cancer stem cells 3, 4 . Intestinal tumorigenesis caused by aberrant Wnt signalling has been modelled successfully in genetically engineered mice 25 . Although tumours in these animals develop predominantly in the small intestine, the disease process mimics much of the cellular and molecular characteristics of human colonic polyposis [25] [26] [27] [28] [29] . Therefore, to determine if intestinal tumours might arise directly from Prom1 1 stem cells, we activated endogenous Wnt signalling in 2-month-old Prom1 1/C-L mice using a Cre-dependent mutant allele of Ctnnb1 (Ctnnb1 lox(ex3) ) 29 and traced the lineage of these cells using the Rosa26-YFP allele. Two days after tamoxifen induction, we observed a marked increase in the number of YFP 1 cells at the base of small intestinal crypts, but at no other site above crypt cell position 4, in Prom1 1/C-L ; Rosa26-YFP; Ctnnb1 1/ lox(ex3) mice relative to Prom1 1/C-L ; Rosa26-YFP; Ctnnb1 1/1 control mice (Fig. 3a) . Twophoton laser-scanning microscopy demonstrated that these cells had a slim and elongated morphology compatible with them being crypt stem cells 2 (Supplementary Movie 1) . Counting of cells isolated from the entire small intestinal mucosae of mice 2 days after tamoxifen induction confirmed the marked expansion in YFP 1 cells in mice containing the Ctnnb1 lox(ex3) allele (P , 0.0001, Wilcoxon test, Fig. 3b ). Cultures of these cells yielded four times as many, and much larger, YFP 1 clonogenic colonies when isolated from Prom1 1/C-L ; Rosa26-YFP; Ctnnb1 1/ lox(ex3) mice compared with those from control animals (P , 0.0001, Wilcoxon test, Fig. 3c, d) . Thus, activation of Wnt signalling in small intestinal Prom1 1 stem cells induces first a marked expansion of these cells in the crypt base. Ten days after tamoxifen induction, Prom1 1/C-L ; Rosa26-YFP; Ctnnb1 1/lox(ex3) crypts were markedly disorganized and contained cells that were uniformly nuclear Ctnnb1 immunoreactive, highly proliferative and disproportionately Prom1 1 (nLacZ immunopositive) relative to controls (Fig. 4a, b and Supplementary Fig. 6a-c ). Contiguous streams of YFP 1 cells were now seen emanating from the crypt and migrating up the surface of the villi (Fig. 4c) . In contrast to Prom1 1/C-L ; Rosa26-YFP; Ctnnb1 1/1 control mice, cells emanating from the crypts of Prom1 1/C-L ; Rosa26-YFP; Ctnnb1 1/lox(ex3) mice were both hyperplastic and grossly dysplastic, forming a carpet of contiguous YFP 1 cells from the base of the crypt to the tip of the villus (compare Figs 2g and 4c). All Prom1 1/C-L ; Rosa26-YFP; Ctnnb1 1/lox(ex3) mice allowed to age after tamoxifen induction succumbed to their disease within 90 days (n 5 15 out of 15). Sixty days after tamoxifen induction, the small intestine of Prom1 1/C-L ; Rosa26-YFP; Ctnnb1 1/lox(ex3) mice was twice the width of that of control animals ( Supplementary Fig. 6d ). Gross inspection of the duodenal, jejunal and ileal lining revealed a thickened, rugous and YFP-fluorescent mucosa; no regions of normal tissue were identified ( Supplementary Fig. 6e, f) . Microscopic analysis revealed loss of the normal villus architecture across the entire small intestine that was replaced by dysplastic tissue, characterized by focal high-grade intraepithelial neoplasia and crypt adenoma formation ( Fig. 4d and Supplementary Fig. 6f ). In contrast, no gross or microscopic abnormalities were seen in the colon which lacks Prom1 1 stem cells ( Supplementary Fig. 6g ). The absence of tumours in the colon in which Ctnnb1 was activated in Prom1 1 differentiated cells points to progenitor cells as the source of tumours in this tissue. All cells in the neoplastic small intestine of Prom1 1/C-L ; Rosa26-YFP; Ctnnb1 1/lox(ex3) mice expressed YFP and nuclear Ctnnb1 and therefore arose from within the Prom1 lineage; however, only 7 6 15.5% (n 5 36 out of 502 YFP 1 cells counted from five separate regions) of tumour cells retained expression of Prom1 (Fig. 4 e-g) . Dual Ki67 and nLacZ coimmunofluorescence analysis of tumours demonstrated that approximately 10% of Prom1 1 tumour cells were proliferating (Fig. 4h ). These data are compatible with the hypothesis that tumours in these animals contain a fraction of transformed stem cells.
Our data demonstrate that Prom1 marks stem cells in the small intestine and that activation of endogenous Wnt signalling in these cells disrupts normal tissue maintenance that begins first in the crypt, expanding aberrantly the Prom1 1 stem cell population, resulting ultimately in neoplastic transformation of the small intestinal mucosa. Therefore, we show that Prom1 marks an adult solid tissue stem cell that is susceptible to neoplastic transformation, forming a model of a human tumour that contains Prom1 1 cancer stem cells. Further analysis will determine whether the fraction of Prom1 1 cells observed in the neoplastic small intestine of Prom1 1/C-L ; Rosa26-YFP; Ctnnb1 1/lox(ex3) mice represents a remnant of mutated stem cells that may function as cancer stem cells. Our Prom1 C-L knockin mouse provides the research community with an extremely useful tool to explore further the relationship between normal and malignant stem cells in the lung, kidney, brain, pancreas and other tissues.
METHODS SUMMARY
Mice. Prom1 C-L mice were generated by homologous recombination in 129SvEv mouse embryonic stem cells targeting a creER T2 -IRES-nlacZ-PGK-neo cassette to the ATG of Prom1. PGK-neo flanked by flip-recombinase target (FRT) sites was subsequently excised by flip recombination by breeding with Rosa26-FLPe mice. Rosa26-YFP reporter and Rosa26-FLPe mice were obtained from the Jackson Laboratory. Ctnnb1 lox(ex3)/lox(ex3) mice were provided by M. Taketo 29 . Mice aged 2 months were treated by oral gavage with 250 ml tamoxifen in corn oil at 40 mg ml 21 for two consecutive days. Histology and microscopy. For nLacZ analysis, YFP microscopy and immunofluorescence, tissues were perfused and fixed in 2% paraformaldehyde (PFA) overnight, cryo-protected and frozen in OCT. For immunohistochemistry, tissues were fixed in 4% PFA and paraffin embedded. In situ probes for Lgr5 and Prom1 were generated from complementary DNA clones and BC156649 and BC028286, respectively. Alcian blue and PAS staining was performed on frozen sections following standard protocols. See Methods for details. Explants and two-photon microscopy. Intestine from tamoxifen-treated mice was removed surgically and immediately submerged in Kreb's solution and superfused with a gas mixture of 95% O 2 /CO 2 . One-millimetre slices were placed on glass coverslips and stabilized with overlying mechanical support and maintained at 37 uC within the microscope chamber. Two-photon laser-scanning microscopy was performed using an Ultima imaging system (Prairie Technologies) and a Ti:sapphire Chameleon Ultra femtosecond-pulsed laser (910 nm) (Coherent). Images were analysed using Imaris software (Bitplane). Three-dimensional images were constructed from Z-series stacks taken in 1 mm steps. Culture of intestinal crypt stem cells. Intestinal epithelial cells were grown in RPMI supplemented with 2 mM L-glutamine, 100 units ml 21 penicillin, 100 mg ml 21 streptomycin and 2.5% FBS. YFP 1 cells and colonies (formed after 4 weeks in culture) were visualized and counted using fluorescence microscopy. See Methods for details.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
